BCA-1

BCA-1

BCA-1, also known as B cell-attracting chemokine 1, is a chemokine involved in the migration and organization of B cells within follicles of lymphoid tissues. It plays a crucial role in the immune response by guiding the movement of B cells to specific sites within the lymph nodes, spleen, and mucosal associated lymphoid tissue (MALT) where they can encounter antigens and participate in the formation of germinal centers. BCA-1 is encoded by the gene CXCL13 and is a member of the CXC chemokine family, characterized by two cysteines separated by a single amino acid.

Function

BCA-1 is primarily expressed in the follicular dendritic cells in the lymphoid tissues. It binds to its receptor, CXCR5, which is predominantly expressed on the surface of B cells and a subset of T cells known as follicular helper T cells (Tfh). The interaction between BCA-1 and CXCR5 plays a vital role in the homing of B cells to the follicles of lymphoid organs, where they can encounter antigens and undergo differentiation into memory B cells or plasma cells. This chemokine is also involved in the formation and maintenance of germinal centers, structures within the follicles that are critical for the affinity maturation of B cells and the development of long-term immunity.

Clinical Significance

Alterations in the expression of BCA-1 or its receptor CXCR5 can lead to disorders in the immune system. Overexpression of BCA-1 has been associated with various autoimmune diseases, such as Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA), where it may contribute to the formation of ectopic lymphoid structures and the perpetuation of the autoimmune response. Additionally, BCA-1 is involved in the pathogenesis of certain types of lymphoma, where it can affect the migration and organization of malignant B cells.

Research

Research on BCA-1 continues to explore its potential as a therapeutic target for autoimmune diseases and certain cancers. By modulating the expression or function of BCA-1 or its receptor, it may be possible to influence the migration and organization of B cells in a way that could benefit patients with autoimmune conditions or B cell malignancies.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian